Skip to main content
Top
Published in: Journal of General Internal Medicine 11/2021

01-11-2021 | Dysthymic Disorder | Viewpoint

Identifying and Addressing Barriers to Transgender Healthcare: Where We Are and What We Need to Do About It

Authors: David Michael Warner II, MS, Arunab Harish Mehta, MD

Published in: Journal of General Internal Medicine | Issue 11/2021

Login to get access

Excerpt

The 2015 United States Transgender Survey (USTS) provided extensive data on the experiences of 27,715 adults with a variety of identities on the transgender spectrum, including transgender, trans, genderqueer, and non-binary. Among the conclusions provided, 33% of respondents seen by a healthcare provider within the year prior to completing the survey reported having at least one negative experience related to their gender identity.1
Literature
1.
go back to reference James, SE, Herman, JL, Rankin, S, Keisling, M, Mottet, L, & Anafi, M. (2016). The Report of the 2015 U.S. Transgender Survey. Washington, DC: National Center for Transgender Equality. James, SE, Herman, JL, Rankin, S, Keisling, M, Mottet, L, & Anafi, M. (2016). The Report of the 2015 U.S. Transgender Survey. Washington, DC: National Center for Transgender Equality.
2.
go back to reference White Hughto, JM, Reisner, SL, Pachankis, JE. Transgender Stigma and Health: A Critical Review of Stigma Determinants, Mechanisms, and Interventions. Soc Sci Med. 2015; 147: 222-231.CrossRef White Hughto, JM, Reisner, SL, Pachankis, JE. Transgender Stigma and Health: A Critical Review of Stigma Determinants, Mechanisms, and Interventions. Soc Sci Med. 2015; 147: 222-231.CrossRef
3.
go back to reference Bakko, M, Kattari, SK. Transgender-Related Insurance Denials as Barriers to Transgender Healthcare: Differences in Experience by Insurance Type. J Gen Intern Med. 2020; 35: 1693-1700.CrossRef Bakko, M, Kattari, SK. Transgender-Related Insurance Denials as Barriers to Transgender Healthcare: Differences in Experience by Insurance Type. J Gen Intern Med. 2020; 35: 1693-1700.CrossRef
4.
go back to reference Obedin-Maliver, J, Goldsmith, ES, Stewart, L, et al. Lesbian, Gay, Bisexual, and Transgender-Related Content in Undergraduate Medical Education. JAMA. 2011;306(9):971-977.CrossRef Obedin-Maliver, J, Goldsmith, ES, Stewart, L, et al. Lesbian, Gay, Bisexual, and Transgender-Related Content in Undergraduate Medical Education. JAMA. 2011;306(9):971-977.CrossRef
5.
go back to reference Chisolm-Straker, M, Jardine, L, Bennouna, C, et al. Transgender and Gender Nonconforming in Emergency Departments: A Qualitative Report of Patient Experiences. Transgender Health. 2017;2(1):8-16.CrossRef Chisolm-Straker, M, Jardine, L, Bennouna, C, et al. Transgender and Gender Nonconforming in Emergency Departments: A Qualitative Report of Patient Experiences. Transgender Health. 2017;2(1):8-16.CrossRef
6.
go back to reference Grant, JM, Mottet, LA, Tanis, J, Harrison, J, Herman, JL, Keisling, M. (2011). Injustice at Every Turn: A Report of the National Transgender Discrimination Survey. Washington, DC: National Center for Transgender Equality and National Gay and Lesbian Task Force. Grant, JM, Mottet, LA, Tanis, J, Harrison, J, Herman, JL, Keisling, M. (2011). Injustice at Every Turn: A Report of the National Transgender Discrimination Survey. Washington, DC: National Center for Transgender Equality and National Gay and Lesbian Task Force.
Metadata
Title
Identifying and Addressing Barriers to Transgender Healthcare: Where We Are and What We Need to Do About It
Authors
David Michael Warner II, MS
Arunab Harish Mehta, MD
Publication date
01-11-2021
Publisher
Springer International Publishing
Published in
Journal of General Internal Medicine / Issue 11/2021
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-021-07001-2

Other articles of this Issue 11/2021

Journal of General Internal Medicine 11/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine